234 related articles for article (PubMed ID: 11159711)
41. In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain.
Adlersberg M; Arango V; Hsiung S; Mann JJ; Underwood MD; Liu K; Kassir SA; Ruggiero DA; Tamir H
J Neurosci Res; 2000 Sep; 61(6):674-85. PubMed ID: 10972964
[TBL] [Abstract][Full Text] [Related]
42. Displacement of the binding of 5-HT(1A) receptor ligands to pre- and postsynaptic receptors by (-)pindolol. A comparative study in rodent, primate and human brain.
Raurich A; Mengod G; Artigas F; Cortés R
Synapse; 1999 Oct; 34(1):68-76. PubMed ID: 10459173
[TBL] [Abstract][Full Text] [Related]
43. Estrogens act in rat hippocampus and frontal cortex to produce rapid, receptor-mediated decreases in serotonin 5-HT(1A) receptor function.
Mize AL; Poisner AM; Alper RH
Neuroendocrinology; 2001 Mar; 73(3):166-74. PubMed ID: 11307035
[TBL] [Abstract][Full Text] [Related]
44. Decreased G-protein coupling of serotonin 5-HT(1A) receptors in the brain of 5-HT(1B) knockout mouse.
Ase AR; Sénécal J; Reader TA; Hen R; Descarries L
Neuropharmacology; 2002 Jun; 42(7):941-9. PubMed ID: 12069904
[TBL] [Abstract][Full Text] [Related]
45. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
[TBL] [Abstract][Full Text] [Related]
46. Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences.
Li Q; Wichems C; Heils A; Lesch KP; Murphy DL
J Neurosci; 2000 Nov; 20(21):7888-95. PubMed ID: 11050108
[TBL] [Abstract][Full Text] [Related]
47. Selective breeding of 5-HT(1A) receptor-mediated responses: application to emotion and receptor action.
Knapp DJ; Sim-Selley LJ; Breese GR; Overstreet DH
Pharmacol Biochem Behav; 2000 Dec; 67(4):701-8. PubMed ID: 11166060
[TBL] [Abstract][Full Text] [Related]
48. WAY100635 prevents the changes induced by fluoxetine upon the 5-HT1A receptor functionality.
Castro E; Díaz A; Rodriguez-Gaztelumendi A; Del Olmo E; Pazos A
Neuropharmacology; 2008 Dec; 55(8):1391-6. PubMed ID: 18809415
[TBL] [Abstract][Full Text] [Related]
49. Pindolol antagonises G-protein activation at both pre- and postsynaptic serotonin 5-HT1A receptors: a.
Newman-Tancredi A; Chaput C; Touzard M; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr; 363(4):391-8. PubMed ID: 11330332
[TBL] [Abstract][Full Text] [Related]
50. Regulation of serotonin-1A receptor function in inducible brain-derived neurotrophic factor knockout mice after administration of corticosterone.
Hensler JG; Advani T; Monteggia LM
Biol Psychiatry; 2007 Sep; 62(5):521-9. PubMed ID: 17336942
[TBL] [Abstract][Full Text] [Related]
51. 8-OHDPAT-induced disruption of prepulse inhibition in rats is attenuated by prolonged corticosterone treatment.
Czyrak A; Maćkowiak M; Chocyk A; Fijał K; Gadek-Michalska A; Wedzony K
Neuropsychopharmacology; 2003 Jul; 28(7):1300-10. PubMed ID: 12700680
[TBL] [Abstract][Full Text] [Related]
52. Differential discrimination of G-protein coupling of serotonin(1A) receptors from bovine hippocampus by an agonist and an antagonist.
Harikumar KG; Chattopadhyay A
FEBS Lett; 1999 Sep; 457(3):389-92. PubMed ID: 10471814
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors.
Orús L; Pérez-Silanes S; Oficialdegui AM; Martínez-Esparza J; Del Castillo JC; Mourelle M; Langer T; Guccione S; Donzella G; Krovat EM; Poptodorov K; Lasheras B; Ballaz S; Hervías I; Tordera R; Del Río J; Monge A
J Med Chem; 2002 Sep; 45(19):4128-39. PubMed ID: 12213056
[TBL] [Abstract][Full Text] [Related]
54. Memory of an operant response and of depressed mood retained in activation states of 5-HT(1A) receptors: evidence from rodent models.
Colpaert FC; Bruins Slot LA; Koek W; Dupuis DS
Behav Brain Res; 2000 Dec; 117(1-2):41-51. PubMed ID: 11099756
[TBL] [Abstract][Full Text] [Related]
55. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
Dong J; De Montigny C; Blier P
Synapse; 1999 Dec; 34(4):277-89. PubMed ID: 10529722
[TBL] [Abstract][Full Text] [Related]
56. Functional effects of chronic electroconvulsive shock on serotonergic 5-HT(1A) and 5-HT(1B) receptor activity in rat hippocampus and hypothalamus.
Gur E; Dremencov E; Garcia F; Van de Kar LD; Lerer B; Newman ME
Brain Res; 2002 Oct; 952(1):52-60. PubMed ID: 12363404
[TBL] [Abstract][Full Text] [Related]
57. Low doses of 8-OH-DPAT prevent the impairment of spatial learning caused by intrahippocampal scopolamine through 5-HT(1A) receptors in the dorsal raphe.
Carli M; Balducci C; Samanin R
Br J Pharmacol; 2000 Sep; 131(2):375-81. PubMed ID: 10991934
[TBL] [Abstract][Full Text] [Related]
58. Short-term effects of 3,4-methylen-dioxy-metamphetamine (MDMA) on 5-HT(1A) receptors in the rat hippocampus.
Giannaccini G; Betti L; Pirone A; Palego L; Fabiani O; Fabbrini L; Mascia G; Giusti L; Macchia M; Giusiani M; Martini C; Lucacchini A
Neurochem Int; 2007 Dec; 51(8):496-506. PubMed ID: 17602794
[TBL] [Abstract][Full Text] [Related]
59. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT(1A) receptors.
Otano A; García-Osta A; Ballaz S; Frechilla D; Del Río J
Br J Pharmacol; 1999 Dec; 128(8):1691-8. PubMed ID: 10588924
[TBL] [Abstract][Full Text] [Related]
60. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
